Related Experiment Videos

Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a

Zhong Chen1, Fangyi Xie, Genshan Ma

  • 1Department of Cardiology, The Affiliated Zhongda Hospital and School of Medicine, Southeast University, No. 87 Dingjiaqiao, Nanjing 210009, People's Republic of China. zhongchen7498@sina.com

Molecular Biology Reports
|February 12, 2011
PubMed

Insights

The GDF-15 -3148C>G variant (rs4808793) is not associated with coronary artery disease (CAD) risk or severity in the Chinese population. Genetic analysis found no link between this specific GDF-15 gene variant and the development or progression of CAD.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Growth differentiation factor (GDF)-15, a member of the transforming growth factor-β superfamily, is linked to cardiovascular diseases.
  • Elevated GDF-15 levels correlate with increased risk of adverse cardiac events and heart failure.
  • The genetic underpinnings of GDF-15's role in cardiovascular disease remain largely unknown.

Purpose of the Study:

  • To investigate the association between the GDF-15 -3148C>G variant (SNP, rs4808793) and the predisposition to coronary artery disease (CAD).
  • To evaluate the relationship between rs4808793 and the severity of coronary artery disease in a Chinese population.

Main Methods:

  • A case-control study involving 418 Chinese participants (192 CAD cases, 226 controls).
  • Genotyping of the GDF-15 -3148C>G variant (rs4808793) using the ligase detection reaction method.
  • Logistic regression analysis to assess the association with CAD risk and severity, stratified by sex.

Main Results:

  • No significant differences in genotype distribution or allele frequencies of rs4808793 were observed between CAD cases and controls.
  • Logistic regression analysis showed no increased risk of CAD associated with CG or GG genotypes, or the G allele compared to CC genotype or C allele.
  • Rs4808793 was not found to be associated with anthropometric/metabolic characteristics or the severity of coronary lesions.

Conclusions:

  • The GDF-15 -3148C>G variant (rs4808793) does not appear to be a significant genetic risk factor for coronary artery disease in the studied Chinese population.
  • This specific GDF-15 gene variant is not associated with the severity of coronary artery disease or key clinical characteristics.
  • Further research may be needed to explore other genetic factors influencing GDF-15 levels and cardiovascular risk.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...